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In trypanosomatids, trypanothione replaces glutathione in all glutathione-
dependent processes. Of the two enzymes involved in the glyoxalase pathway,
glyoxalase I and glyoxalase II, the latter shows absolute specificity towards
trypanothione thioester, making this enzyme an excellent model to understand
the molecular basis of trypanothione binding. Cloned glyoxalase II from
Leishmania infantum was overexpressed in Escherichia coli, purified and
crystallized. Crystals belong to space group C2221 (unit-cell parameters a = 65.6,
b = 88.3, c= 85.2 A˚) and diffract beyond 2.15 A˚ using synchrotron radiation. The
structure was solved by molecular replacement using the human glyoxalase II
structure as a search model. These results, together with future detailed kinetic
characterization using lactoyltrypanothione, should shed light on the evolu-
tionary selection of trypanothione instead of glutathione by trypanosomatids.
1. Introduction
Trypanosomatids, the causal agents of several human and animal
diseases worldwide, present two characteristics that set them apart
from all other living organisms. Firstly, glycolysis, the most funda-
mental biochemical pathway, occurs in these organisms within a
specific organelle, the glycosome (Hannaert et al., 2003). Secondly,
the unique thiol N1,N8-bis(glutathionyl)spermidine (trypanothione)
replaces glutathione in similar eukaryotic glutathione-dependent
reactions (Muller et al., 2003; Fairlamb & Cerami, 1992). These
differences may be exploited in the development of novel therapeutic
strategies, considering that diseases caused by trypanosomatids have
no effective curative therapies and are often lethal. Synergistic effects
of simultaneous inhibition of multiple trypanothione-dependent
enzymes might prove to be the best option, given the absolute need
for this thiol during the life cycle of the parasite (Oza et al., 2003).
The glyoxalase pathway is one of the important systems that
depend on trypanothione. In trypanosomatids, this system is
composed of the two enzymes glyoxalase I (lactoylglutathione lyase;
EC 4.4.1.5) and glyoxalase II (hydroxyacylglutathione hydrolase; EC
3.1.2.6), which are specific for trypanothione and lactoyl-
trypanothione, respectively (Sousa Silva et al., 2005; Irsch & Krauth-
Siegel, 2004). Glyoxalase II shows absolute specificity towards
trypanothione thioester, in contrast to glyoxalase I, which can also
react with glutathione-methylglyoxal hemithioacetal (Sousa Silva et
al., 2005). Thus, it is an excellent model to understand the molecular
basis of trypanothione specificity.
L. infantum glyoxalase II is a monomeric protein with 295 residues
(molecular weight 32.5 kDa) and shares 35% homology with the
human glutathione-dependent glyoxalase II (Cameron et al., 1999).
Here, we report the purification, crystallization and preliminary
X-ray diffraction analysis of L. infantum glyoxalase II. Its structure
determination will shed some light onto the structure–function rela-
tionships of the trypanothione-dependent glyoxalase II.
2. Materials and methods
2.1. Cloning, expression and purification
The LiGLO2 gene was amplified from L. infantum (clone MHOM/
MA67ITMAP263) genomic DNA. The PCR product was cloned into
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theNdeI/XhoI-digested expression vector pET-28a (Novagen), which
was then transformed into Escherichia coli BL21-Codon Plus (Stra-
tagene). For overexpression of His6-glyoxalase II, BL21-Codon Plus
transformants were grown in LB medium containing 50 mg ml1
kanamycin and 100 mg ml1 chloramphenicol at 310 K. When the
culture reached an OD600 nm of 0.6, expression was induced with
0.2 mM isopropyl -d-thiogalactopyranoside (IPTG) for 3 h at 310 K.
The fusion protein, with an N-terminal tail of six histidines and a
thrombin cleavage site (the total tag sequence including linker and
cleavage site is HHHHHHSSGLVPRGSH), was purified at 277 K by
chromatography on a His-Bind resin (Novagen) column. His6-
LiGLO II was eluted with an imidazole gradient from 5 mM to 1M at
a flow rate of 2.5 ml min1. Fractions containing glyoxalase II
(confirmed by SDS–PAGE) were pooled and the buffer was
exchanged to 1 PBS pH 7.4 using PD-10 columns (Amersham
Biosciences). The purity of the recombinant glyoxalase II was esti-
mated by SDS–PAGE. The His6-LiGLO II was concentrated to
25 mg ml1 in 10 mM HEPES pH 7.0 using Amicon Ultra-4 filters
(10 000 NMWL; Millipore Corporation).
2.2. Crystallization
Crystallization conditions were obtained with an in-house screen of
80 conditions at 293 K, applying the hanging-drop vapour-diffusion
method using the crystallization tools from Nextal Biotechnology.
Drops were prepared by mixing 2 ml protein solution with 2 ml of each
precipitant solution equilibrated over 700 ml reservoir solution.
Several conditions in the crystallization screen produced crystals.
Crystals were obtained from various conditions including PEGs of
molecular weight ranging from 400 to 8000, MES or MOPS with pH
between 5.5 and 7.0 and sodium or ammonium acetate as salt
components. The best crystals were obtained by mixing 1 ml protein
solution with 2 ml reservoir solution containing 30%(w/v) PEG 8000,
0.2M magnesium chloride and 0.1M sodium acetate buffer pH 5.5.
This final crystallization condition resulted in thick plates, which grew
within 2 d to maximum dimensions of approximately 0.16  0.06 
0.02 mm at 288 K (Fig. 1).
2.3. Data collection and processing
Crystals were directly flash-cooled in the cryostream without any
additional cryoprotectant. All data were collected at 100 K. A low-
resolution data set was collected in-house using a Cu K Enraf–
Nonius rotating-anode generator operated at 5 kW and a MAR
Research image-plate detector (Table 1). A high-resolution native
data set was measured at beamline ID14-1 at the European
Synchrotron Radiation Facility (ESRF) in Grenoble (France) using
an ADSC Quantum 4R CCD detector. The crystal diffracted beyond
2.15 A˚.
The diffraction experiments showed that glyoxalase II crystals
belong to space group C2221, with unit-cell parameters a = 65.7,
b = 88.3, c = 85.2 A˚.
The data were processed usingMOSFLM v.6.2.5 (Leslie, 1992) and
scaled using SCALA from the CCP4 program package v.6.0 (Colla-
borative Computational Project, Number 4, 1994). In order to esti-
mate the protein content of the asymmetric unit, the Matthews
coefficient VM (Matthews, 1968) and solvent content were calculated
based on a subunit molecular weight of 32.5 kDa (predicted from the
sequence). The structure was solved by molecular replacement using
the full structure of the human homologue (PDB code 1qh3; after
removing all non-protein atoms) as a search model and the program
Phaser (Read, 2001) from the CCP4 suite.
3. Results and discussion
The L. infantum LiGLO2 gene (GenBank accession No. DQ294972)
was cloned and expressed in E. coli BL21 Codon Plus cells. The
protein was expressed with an N-terminal His-tag fusion. A
nickel-affinity column was used for purification. The purity of the
recombinant L. infantum His-glyoxalase II was 95% as estimated
by SDS–PAGE, which showed a single band corresponding to a
molecular weight of about 32 kDa.
After optimization of the crystal-growth process, the purified
protein produced thick plate crystals within 2 d (Fig. 1) which
diffracted beyond 2.15 A˚ resolution using synchrotron radiation. The
crystals belong to space group C2221, with unit-cell parameters
a = 65.7, b = 88.3, c = 85.2 A˚. The calculated Matthews coefficient is
1.88 A˚3 Da1, corresponding to a solvent content of35%, assuming
the presence of one molecule in the asymmetric unit (Matthews,
1968). Data-collection and processing statistics are shown in Table 1.
Molecular replacement was performed using the human glyoxalase
II structure (Cameron et al., 1999; PDB code 1qh3; the full model was
used), which shows 35% sequence identity with the L. infantum
glyoxalase II, as a search model and the molecular-replacement
program Phaser (Read, 2001). One clear solution was obtained and
the calculated phases were improved using Pirate (Cowtan, 2000). A
preliminary C trace was manually built from the search model and is
currently being rebuilt using COOT (Emsley & Cowtan, 2004) and
refined with REFMAC5 from the CCP4 suite (Collaborative
Computational Project, Number 4, 1994).
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Figure 1
Crystals of L. infantum glyoxalase II.
Table 1
Crystal data and data-collection statistics.
Values in parentheses are for the highest resolution shell.
Data set In-house ESRF
Space group C2221
Unit-cell parameters (A˚) a = 66.6, b = 90.1,
c = 85.8
a = 65.6, b = 88.3,
c = 85.2
Source In-house Cu K ID14-1
Wavelength (A˚) 1.542 0.934
No. of observed reflections 170772 209900
No. of unique reflections 7294 13574
Resolution limits (A˚) 30.0–2.7 (2.85–2.7) 30.0–2.15 (2.27–2.15)
Redundancy 6.0 (5.7) 5.4 (5.2)
Rsym† (%) 14.2 (47.7) 10.6 (42.5)
Completeness (%) 99.9 (99.9) 98.4 (98.4)
hI/(I)i 5.3 (1.6) 5.7 (1.7)
† Rsym =
P
h
P
l jIhl  hIhij=
P
h
P
lhIhi, where Il is the lth observation of reflection h and
hIhi is the weighted average intensity for all observations l of reflection h.
The structure of L. infantum glyoxalase II, together with complete
biochemical studies, will provide important insights into the mole-
cular basis of trypanothione specificity.
The authors would like to thank the beamline staff at ID14-1 for
assistance during data collection at the ESRF, Grenoble, France. This
work was supported by projects POCTI/ESP/48272/2002 and BPD-
9444/2002 (JT) from the Fundac¸a˜o para a Cieˆncia e Tecnologia,
Ministe´rio da Cieˆncia e Tecnologia, Portugal.
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